Thiopurine methyltransferase (TPMT; EC 2.1.1.67) catalyses the S-methylation of azathioprine, 6-thioguanine and 6-mercaptopurine (6-MP). 1) These three drugs are used for the treatment of patients with several disorders such as acute lymphoblastic leukemia, rheumatoid arthritis, systemic lupus erythematosus or other autoimmune/inflammatory diseases as well as of those undergoing organ transplants. [2] [3] [4] Since lack of TPMT activity may cause life-threatening 6-MP toxicity, detection of TPMT deficiency before use of these drugs is very important. Determination of TPMT activity however, is complicated and too time-consuming for application in routine consulting.
An existence of the genetic polymorphism of the TPMT activity in humans was first reported by Weinshilboum and Sladek (1980) . 5) At present, 11 mutant alleles of TPMT which are associated with intermediate or low TPMT activity have been reported (Table 1) . 1, [6] [7] [8] [9] [10] [11] [12] [13] [14] Based upon the relationship between TPMT genotype and phenotype, TPMT*2, *3A, *3B and *3C alleles have been identified as a clinically relevant TPMT mutation in many patients, and in healthy subjects. 9, 15) Further, TPMT*4, *5, *6, *7, *8 have also been suspected to be associated with low TPMT activity. [11] [12] [13] [14] Recently, even heterozygous genotypes have been indicated as presenting a greater risk of thiopurine toxicity. [16] [17] [18] Therefore, it is essencial to determine the TPMT genotype of patients before beginning thiopurine therapy.
Pyrosequencing is a non-electrophoretic, real-time DNA sequencing method which is based upon an enzyme mixture reaction followed by a luciferase-luciferin light release reaction to detect the signal of the specific nucleotide incorporation into the target DNA. 19) To establish a simple and rapid method for genotyping of TPMT mutants for clinical use, we developed a pyrosequencing method for the detection of TPMT mutations (TPMT*1S-*8).
MATERIALS AND METHODS

Synthesis of Oligonucleotides
The oligonucleotide primers used for amplification and sequencing have been described previously by Krynetski et al. 20) (Table 2) , and were obtained from KURABO Industries Ltd. (Osaka, Japan). The 5Ј-end biotinylation for the PCR primer of either side (forward or reverse) was performed. The primers used for pyrosequencing listed in Table 3 were obtained from Hokkaido System Science Co., Ltd. (Sapporo, Japan).
DNA Samples DNA samples were obtained from 96 Japanese subjects (ages 19-71, mean age 37.1, 22 male and 74 female). DNA analyses of drug metabolizing enzymes including TPMT were approved by the Institutional Review Board for Clinical Trials at Gunma University Hospital. Written informed consent was obtained from all participants after being informed of the experimental procedure.
Genomic DNA was extracted from peripheral leukocytes in 0.2 ml of whole blood using a QIAamp ® Blood Kit (QIA-GEN, Valencia, CA). DNA was resuspended in 100 ml of TE buffer (10 mmol/l Tris, 1 mmol/l EDTA, pH 8.0) and stored at 4°C until analysis. DNA reference samples with TPMT*2 homozygous, *1/*3A heterozygous, and *1/*8 heterozygous 
PCR and Primers
Fragments of the TPMT gene (exon 4, 5, 7, 8, 10) were amplified as described previously with slight modification. 20) The PCR reaction was performed in a total volume of 50 ml, using 100 ng of human genomic DNA, 50 mmol/l Tris-HCl (pH 8.3), 8.0 mmol/l MgCl 2 , 0.5 mmol/l of each primers (Table 2 ) and 1 unit of AmpliTaq Gold TM DNA polymerase (Applied Biosystems, Foster City, CA). The initial denaturation step was performed at 94°C for 8 min, followed by 25 cycles of denaturation at 94°C for 30 s, annealing at 59°C for 30 s with extension at 72°C for 30 s, and the final extension occurred at 72°C for 4 min. All of these steps were undertaken using a GeneAmp ® PCR System 9700 Thermal Cycler (Applied Biosystems, Foster City, CA).
Single-Strand Template Preparation for Pyrosequencing TM
Purification of primers and nucleotides remaining in the PCR reaction mixture is necessary prior to pyrosequencing. A solution of 25 ml of biotinylated PCR product combined with 25 ml 2X Binding-Washing buffer II pH 7.6 (10 mmol/l Tris-HCl, 2 mol/l NaCl, 1 mmol/l EDTA, 0.1% Tween ® 20) was immobilized onto 100 mg streptavidincoated super paramagnetic beads (Dynabeads ® M-280; Dynal AS, Oslo, Norway) by incubation at 65°C for 15 min with constant agitation using a thermal mixer (Thermomixer; Eppendorf AG, Hamburg, Germany) to keep the beads dispersed. The immobilized sample was rinsed twice with 1X Annealing buffer (20 mmol/l Tris-Acetate (pH7.6) and 5 mmol/l Mg-acetate). Single-stranded DNA was obtained by incubating the immobilized PCR product in 50 ml of 0.5 mol/l NaOH for 1 min. The eluted strand was neutralized in 100 ml of 1X Annealing buffer. The immobilized strand was resolved in 45 ml of 1X Annealing buffer. Singlestranded DNA was hybridized to 10 pmol of the sequencing primer (Table 3) at 80°C for 2 min, followed by incubation at room temperature for 15 min.
In the case of exon 7, there are two mutation sites, 460 GϾA and 474 GϾC, and the distance between these sites is only 14 bp. Both of the mutants were detected at the same time using the sequencing primer 460 GϾA-474 GϾC, since pyrosequencing can determine 10-20 base pairs of a target sequence. The sequencing primer for the detection of 460 GϾA and 474 GϾC was designed as down stream of the mutation sites, because it is difficult to design a specific sequencing primer up stream of G460, probably due to high homology sequence within TPMT gene.
Exon 10 was amplified using PCR primer 129 and 131 (301 bp). There are 4 single nucleotide polymorphisms (SNPs) (Intron 9 GϾA, 644 GϾA, 681 TϾG, 719 AϾG) in exon 10 within a range of 90 bp. We used 4 sequencing primers (Intron 9 GϾA, 644 GϾA, 681 TϾG, 719 AϾG) to detect the 4 SNPs. We also attempted to detect four SNPs simultaneously using two sequencing primers (Intron 9 GϾA, 681 TϾG). Both Intron 9 GϾA and 644 GϾA were successfully detected, while 681 TϾG and 719 AϾG were not because the distance between two SNPs is too great (38 bp). Detection of the remaining SNPs was undertaken using the PCR primers and sequencing primers listed in Tables 2, 3 , respectively.
SNPs Genotyping by Pyrosequencing Pyrosequencing was performed at room temperature using an automated pyrosequencer (PSQ96, Pyrosequencing AB, Uppsala, Sweden) at a dispensing pressure of 650 mbar with 9 ms of open time and a 65 s cycle time. Purified single-stranded DNA was es-678
Vol. 28, No. 4 tablished as the template in pyrosequencing reactions using a PSQ TM 96 SNP reagent kit as described by the manufacturer (Pyrosequencing AB, Uppsala, Sweden). The output of light resulting from nucleotide incorporation was measured with a charged-coupled device (CCD) camera. In order to facilitate the detection of known SNP sites, the number of nucleotide additions can be reduced by using a SNP specific dispensing protocol.
Dye-Terminator Cycle Sequencing The sequencing data obtained from pyrosequencing were confirmed by direct sequencing using BigDye ® chemistry reaction protocol (Applied Biosystems Foster City, CA). Each cycle-sequencing reaction (total 10 ml) contained 1 ml purified PCR product, 4 ml dye-terminator reaction mixture, 1.6 pmol primer. Cycle sequencing was started at 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min. We purified the cycle-sequencing reactions using Centri-Sep (Applied Biosystems, Foster City, CA) and analyzed them on an ABI PRISM ® 3100 sequencer (Applied Biosystems, Foster City, CA). middle and lower panel of each mutation site represent wildtype homozygous, heterozygous and mutant homozygous, respectively. Examples of 146 TϾC homozygous, 292 GϾT heterozygous and homozygous, 460 GϾA homozygous, 539 AϾT heterozygous and homozygous, Intron 9 GϾA homozygous, 644 GϾA homozygous, and 681 TϾG heterozygous and homozygous are not shown due to lack of genome DNA for these variants. Figure 1B shows the sequencial addition of nucleotides for the detection of each mutation site. Because the sequence of the SNP is known, the order of nucleotide additions was arranged by SNP specific dispensing protocol. The nucleotides identified with arrows in the predicted pyrograms TM (Fig. 1B) were negative internal controls in the pyrosequencing reactions. Since the peak value in the pyrogram TM is proportional to the number of the nucleotides incorporated using polymerase, we can easily estimate the sequence obtained from the pyrogram TM . In the case of 146 TϾC ( Fig. 1-1) , for example, homozygous T (top panel), the nucleotide dispensation T2 generates a peak corresponding to one pair of base (T). In the heterozygous situation (middle panel), a peak for (T) decreases by 50%, and a peak with similar height appears after the addition of a third nucleotide (C). When the SNP position is homozygous C (lower panel), the addition of (T) does not generate a peak, and the addition of (C) generates a peak corresponding to one pair of base (C). As shown in Fig.  1 , the raw data (Fig. 1C) completely matches the predicted pyrogram TM (Fig. 1B) , and is consistent with the results obtained using conventional DNA sequencing procedure (Fig.  1D) .
RESULTS
Since the distance between Intron 9 GϾA (TPMT*4) and 644 GϾA (TPMT*8) mutation is 19 bp in exon 10, we could determine 2 SNPs using only one sequencing primer (Fig. 2) . The peak for (G) is two times higher than the peak for (A) at the site of Intron 9 GϾA, indicating wild type (G) homozygous. At the 644 GϾA mutation site, homozygous wild-type was indicated because the peak for (A) could not be detected (right). In the case of exon 7, there are two SNPs (460 GϾA and 474 TϾC) with the distance of only 14 bp, therefore it was also possible to identify these SNPs using only one sequencing primer same as Intron 9 GϾA (TPMT*4) and 644 GϾA (TPMT*8).
Since the TPMT*2, *3A, *3B, *3D, *4, *5, *7 and *8 variants were not detected in any of the Japanese samples analyzed, we obtained reference genomes (Fig. 1) for these mutations from other investigators in order to verify the validity of our method. The results of this pyrosequencing method corresponded exactly with those of the DNA sequencing method using BigDye terminator chemistry. We can finish preparation of the samples for pyrosequencing within 30 min after PCR and it took 20 min to complete a pyrosequencing of a sample. Pyrosequencing itself took approximately 20 min.
DISCUSSION
TPMT*3C is the most frequent mutant TPMT allele in Japanese populations. 21, 22) Additionally rare phenotype variants (TPMT*3B, *3D, *4, *5, *6, *7 and *8) and some intronic and silent mutations have been reported in Northern European, Korean, African-American and Caucasian populations. 9, 11, 12) There were no TPMT*2, *3A, *3B, *4, *5, *6, *7 and *8 variants detected in any of the Japanese samples analyzed in this study. In three cases (292 GϾT, 539 AϾT, 681 TϾG), only the wild-type sequence could be demonstrated because of no reference sample. The results of these pyrosequencing data corresponded exactly with the DNA sequencing result. We believe that there is little possibility of falsenegative error.
PCR-RFLP and allele-specific PCR have been used for the detection of TPMT mutation.
9) PCR-RFLP is frequently used for genotyping when working with a few samples, because the equipment and running costs are minimal for SNPs detection. PCR-RFLP however requires significant time for the restriction enzyme reaction and the following electrophoresis procedure. The process of restriction enzyme reaction depends on SNPs. In addition, errors could occur due to the low activity of the restriction enzyme, caused by experimental conditions involving both buffer and the enzymes. Therefore, the use of positive control DNA, and calculation the densities of the bands are recommended in order to avoid such errors. For these reasons, the PCR-RFLP method may not be ideal when applied to routine clinical practice.
Recently, real-time PCR approach 23) and denaturing HPLC procedure 24) for TPMT genotyping were published. In realtime PCR assay, PCR conditions had to be optimized with respect to both PCR primers and probes, and the procedure of the assay is laborious consequently, compared to pyrosequencing. Also, reliability of the real-time PCR reaction depends on conditions. The amplification failed to proceed during even slight variations in, for example, primer concentration. 25) The denaturing HPLC offers a highly sensitive and efficient method for genotyping of TPMT, but requires significant time (more than 1.5 h) after PCR procedure, compared to pyrosequencing.
Pyrosequencing is a new method performed in an automated microtiter-based instrument. As shown in our results, it is possible to analyze 10-20 sequences for 96 samples within 20 min after the sample preparation for Pyrosequencing. Each round of nucleotide dispensing takes approximately 1 min and thus offers a rapid way to determine the exact sequence around SNPs. Since pyrosequencing can determine 10-20 base pairs of a target sequence, we could determine two consecutive SNPs using only one sequencing primer, if their distance was less than 20 bp. The cost of pyrosequencing was approximately 300 yen/sample, from PCR product to complete analysis. Even though Pyrosequencing is one of the clinically useful methods for detection of gene variants, this method could be still not free from making error, due to wrong protocols and sampling. PCR-RFLP could misjudge the result in case of low activity of the restriction enzyme, due to buffer conditions and inactivation of the restriction enzymes. Since the peak height obtained by the pyrosequencing method is quantitative, the possibility of misjudgment due to incomplete reaction can be excluded. On the other side, simple artificial mistake during the sample treatment is inevitable error for all the methods. In clinical use of these genotyping methods, mistake sampling may be serious problem.
At present, the two SNPs (719 AϾG 21, 22) and 539 AϾT 26) ) have been reported in the Japanese population, and there was no report about 460 GϾA mutant. If the subject who had 460 GϾA heterozygous and 719 AϾG heterozygous is found, we should determine whether the subject is intermediate metabolizer (TPMT*1/*3A and *1/*3D) or poor metabolizer (TPMT*3B/*3C). McDonald et al., 27) designed the haplotype analysis for three SNPs (238 GϾC, 460 GϾA, 719 AϾG) in the TPMT gene using self ligation. We will be able to haplotype with some modification of the method.
In conclusion, we have developed a precise, fast and efficient method for identifying individual TPMT genotypes using a pyrosequencer. This method might be quite powerful tool for the detection of the patients with TPMT deficiency to avoid severe toxicities before treated by thiopurine drugs.
